Home 2017
Archives
ADA: Degludec Noninferior for Cardiovascular Events in T2DM
Noninferior to glargine for incidence of major cardiovascular events in high-risk patients with T2DM
ADA: Canagliflozin Tied to Lower Risk of Cardiovascular Events
Lower risk versus placebo for patients with type 2 diabetes and high cardiovascular risk
ADA: Nasal Glucagon Feasible for Hypoglycemic Episodes
New product much easier to use than rescue injections, researcher says
SLEEP: Helpful Hints From Bed Partner Can Exacerbate Insomnia
Bed partners can unintentionally contribute to the perpetuation of insomnia
ADA: Glucose Self-Monitoring Often Lacks Benefit in T2DM
No significant improvements in hemoglobin A1c levels, HRQOL seen in non-insulin-treated cases
Several New Medications in the Pipeline to Prevent Migraine
New injectable drugs work by targeting calcitonin gene-related peptide
Obesity Prevalence Has Doubled in More Than 70 Countries
From 1980 to 2015 there was a continuous increase in obesity prevalence in most other countries
SLEEP: Weekend Sleep Changes Adversely Affect Health Outcomes
For every hour of shifted sleep, an associated 11.1 percent increase in risk of diagnosed heart disease
SLEEP: Prolonged Delayed Eating Linked to Weight Gain
Compared with daytime eating, delayed eating also linked to increases in respiratory quotient
APSS: Weekend Sleep Changes Adversely Affect Health Outcomes
For every hour of shifted sleep, an associated 11.1 percent increase in risk of diagnosed heart disease
